Dr. med. Dr. rer. nat. Karl Bihlmaier
Oberarzt für Innere Medizin und Nephrologie, Zusatzbezeichnung Intensivmedizin

Einrichtungen
Medizin 4
Lebenslauf, Veröffentlichungen und Auszeichnungen
Publikationen
- (2023) Fatal Puumala Hantavirus Infection in a Patient with Common Variable Immunodeficiency (CVID). Microorganisms. 2023;11(2):
- (2023) EXCHANGE-2: investigating the efficacy of add-on plasma exchange as an adjunctive strategy against septic shock-a study protocol for a randomized, prospective, multicenter, open-label, controlled, parallel-group trial. Trials. 2023;24(1):
- (2023) β-(1→3)-D-glucan- and mannan-guided early termination of antifungal therapy in ICU patients: a randomized controlled study. Antimicrob Agents Chemother. 2023;67(11):
- (2023) Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications. J Am Coll Cardiol. 2023;82(19): 1809-1823
- (2022) Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation. Crit Care. 2022;26(1):
- (2022) Endogenous <i>De Novo</i> Synthesis of Isopropanol Following Severe Non-Diabetic Ketoacidosis in a Patient With Duchenne Muscular Dystrophy J Endocrinol Metab. 2022;12(3): 107-110
- (2020) Disseminated Multifocal Intracerebral Bleeding Events in Three Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation As Rescue Therapy. Crit Care Explor. 2020;2(9):
- (2020) Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. 2020;395(10234): 1444-1451



